Saturday, Aug 8, 2026

"zendal-group"

Biofabri, Bharat Biotech sign technology transfer agreement for MTBVAC TB vaccine

Biofabri and Bharat Biotech International Limited signed a technology transfer agreement to ensure the MTBVAC TB vaccine is manufactured in India. After successful Phase I and II trials, BBIL plans a Phase III study starting in early 2026.

Latest News

Ashmita Chaliha reaches Korea Masters Super 300 final

3 mins ago
I am proud of you all: PM Modi to IIT Delhi students

7 mins ago
Implement 2023 law without conditions: Rahul Gandhi to Rijiju

51 mins ago
Two killed, four critical as Kerala bus overturns on Bengaluru-Mysuru Expressway

57 mins ago
Jharkhand exam protest: Student delegation, govt meet for 2nd round of talks

1 hour ago
Four killed in two road accidents in erstwhile Medak

2 hours ago
IAF officer arrested over defence information leak, probe on

2 hours ago
Uttarakhand CM responds to Rishabh Pant’s land request

3 hours ago